Start Assessment

Prostate information
and resources

Start Assessment

Thank you for your interest in the prostate cancer case finding service.

This service was set up in 2022 to find people who were unable to visit their GP due to the COVID-19 pandemic and who are more at risk of having prostate cancer than others.

The service closes in March 2024 and we are no longer accepting new patients.

If you have any concerns about prostate cancer or if you would still like to have a PSA test, you can discuss this with your GP, and they will offer advice.

If you are experiencing any worrying symptoms, please make an appointment with your GP as soon as possible. If you would like a reminder of what symptoms to look out for, please follow this link: What are the symptoms associated with prostate cancer?

If you have already arranged a PSA test, have questions relating to an upcoming appointment or test results, please call our Patient Care Team on 0800 111 4314. Lines are open Monday to Friday, 8am to 6pm.

Understand more about the risks
and treatments of prostate cancer

Prostate cancer, why is it a problem?

Prostate cancer is the most common cancer in men in the UK.

What is the prostate?

If you were assigned male at birth, then you have something called a prostate gland.

What are the symptoms associated with prostate cancer?

The majority of men with early prostate cancer do not have any symptoms - find out more about prostate cancer symptoms
More prostate information

Find out
if you need
a Prostate
Cancer test

Start Assessment Click here

Working in partnership for early diagnosis of prostate cancer

“Talk Prostate” is the result of a partnership between the Surrey and Sussex NHS Cancer Alliance (SSCA) and virtual NHS healthcare provider, Medefer.

The partnership was established in spring 2022 as there was a drop in the number of suspected prostate cancer referrals in the Surrey and Sussex Region due to the Covid-19 pandemic.

Prostate cancer is the most common cancer killer in men. While survival rate is high for early disease (78%) compared to other cancers, we still lose over 12,000 men to this disease every year in the UK.

Click here to find out more about Talk Prostate, Medefer and the Surrey & Sussex NHS Cancer Alliance